BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26922657)

  • 1. GABAergic system impairment in the hippocampus and superior temporal gyrus of patients with paranoid schizophrenia: A post-mortem study.
    Steiner J; Brisch R; Schiltz K; Dobrowolny H; Mawrin C; Krzyżanowska M; Bernstein HG; Jankowski Z; Braun K; Schmitt A; Bogerts B; Gos T
    Schizophr Res; 2016 Nov; 177(1-3):10-17. PubMed ID: 26922657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced GABAergic neuropil and interneuron profiles in schizophrenia: Complementary analysis of disease course-related differences.
    Förster A; Model V; Gos T; Frodl T; Schiltz K; Dobrowolny H; Meyer-Lotz G; Guest PC; Mawrin C; Bernstein HG; Bogerts B; Schlaaff K; Steiner J
    J Psychiatr Res; 2021 Nov; 145():50-59. PubMed ID: 34864489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences between unipolar and bipolar I depression in the quantitative analysis of glutamic acid decarboxylase-immunoreactive neuropil.
    Gos T; Steiner J; Bielau H; Dobrowolny H; Günther K; Mawrin C; Krzyżanowski M; Hauser R; Brisch R; Bernstein HG; Jankowski Z; Braun K; Bogerts B
    Eur Arch Psychiatry Clin Neurosci; 2012 Dec; 262(8):647-55. PubMed ID: 22526728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suicide and depression in the quantitative analysis of glutamic acid decarboxylase-Immunoreactive neuropil.
    Gos T; Günther K; Bielau H; Dobrowolny H; Mawrin C; Trübner K; Brisch R; Steiner J; Bernstein HG; Jankowski Z; Bogerts B
    J Affect Disord; 2009 Feb; 113(1-2):45-55. PubMed ID: 18538859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of glutamate decarboxylase65 immunoreactive puncta on pyramidal and nonpyramidal neurons in hippocampus of schizophrenic brain.
    Todtenkopf MS; Benes FM
    Synapse; 1998 Aug; 29(4):323-32. PubMed ID: 9661250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereological quantification of GAD-67-immunoreactive neurons and boutons in the hippocampus of middle-aged and old Fischer 344 x Brown Norway rats.
    Shi L; Argenta AE; Winseck AK; Brunso-Bechtold JK
    J Comp Neurol; 2004 Oct; 478(3):282-91. PubMed ID: 15368530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organization of the GABAergic system in the rat hippocampal formation: a quantitative immunocytochemical study.
    Woodson W; Nitecka L; Ben-Ari Y
    J Comp Neurol; 1989 Feb; 280(2):254-71. PubMed ID: 2925894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of mRNAs encoding two forms of glutamic acid decarboxylase in the rat hippocampal formation.
    Houser CR; Esclapez M
    Hippocampus; 1994 Oct; 4(5):530-45. PubMed ID: 7889124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamic acid decarboxylase-67-positive hippocampal interneurons undergo a permanent reduction in number following kainic acid-induced degeneration of ca3 pyramidal neurons.
    Shetty AK; Turner DA
    Exp Neurol; 2001 Jun; 169(2):276-97. PubMed ID: 11358442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia.
    Heckers S; Stone D; Walsh J; Shick J; Koul P; Benes FM
    Arch Gen Psychiatry; 2002 Jun; 59(6):521-9. PubMed ID: 12044194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunofluorescently labeling glutamic acid decarboxylase 65 coupled with confocal imaging for identifying GABAergic somata in the rat dentate gyrus-A comparison with labeling glutamic acid decarboxylase 67.
    Wang X; Gao F; Zhu J; Guo E; Song X; Wang S; Zhan RZ
    J Chem Neuroanat; 2014 Nov; 61-62():51-63. PubMed ID: 25058170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation of GABAergic neurotransmission in mood disorders: a postmortem study.
    Bielau H; Steiner J; Mawrin C; Trübner K; Brisch R; Meyer-Lotz G; Brodhun M; Dobrowolny H; Baumann B; Gos T; Bernstein HG; Bogerts B
    Ann N Y Acad Sci; 2007 Jan; 1096():157-69. PubMed ID: 17405927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunocytochemical investigation of L-glutamic acid decarboxylase in the rat hippocampal formation: the influence of transient cerebral ischemia.
    Johansen FF; Lin CT; Schousboe A; Wu JY
    J Comp Neurol; 1989 Mar; 281(1):40-53. PubMed ID: 2925901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein malnutrition differentially alters the number of glutamic acid decarboxylase-67 interneurons in dentate gyrus and CA1-3 subfields of the dorsal hippocampus.
    Díaz-Cintra S; González-Maciel A; Morales MA; Aguilar A; Cintra L; Prado-Alcalá RA
    Exp Neurol; 2007 Nov; 208(1):47-53. PubMed ID: 17706195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal circuit-dependent alterations in expression of two isoforms of glutamic acid decarboxylase in the hippocampus following electroconvulsive shock: A stereology-based study.
    Jinno S; Kosaka T
    Hippocampus; 2009 Nov; 19(11):1130-41. PubMed ID: 19283776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia.
    Dracheva S; Elhakem SL; McGurk SR; Davis KL; Haroutunian V
    J Neurosci Res; 2004 May; 76(4):581-92. PubMed ID: 15114630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamate decarboxylase(65)-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain.
    Benes FM; Todtenkopf MS; Logiotatos P; Williams M
    J Chem Neuroanat; 2000 Dec; 20(3-4):259-69. PubMed ID: 11207424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered DARPP-32 expression in the superior temporal gyrus in schizophrenia.
    Kunii Y; Yabe H; Wada A; Yang Q; Nishiura K; Niwa S
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1139-43. PubMed ID: 21453742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of the synaptic protein rab3a in the thalamus and connecting brain regions in post-mortem schizophrenic brains.
    Blennow K; Bogdanovic N; Heilig M; Grenfeldt B; Karlsson I; Davidsson P
    J Neural Transm (Vienna); 2000; 107(8-9):1085-97. PubMed ID: 11041284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced microglial immunoreactivity for endogenous NMDA receptor agonist quinolinic acid in the hippocampus of schizophrenia patients.
    Gos T; Myint AM; Schiltz K; Meyer-Lotz G; Dobrowolny H; Busse S; Müller UJ; Mawrin C; Bernstein HG; Bogerts B; Steiner J
    Brain Behav Immun; 2014 Oct; 41():59-64. PubMed ID: 24886967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.